MIDAZOLAM , CEDACONDA 100 % V/V, liquide pour inhalation par vapeur, PROPOFOL
APHP230844
Phase 3 small_molecule active
Quick answer
MIDAZOLAM , CEDACONDA 100 % V/V, liquide pour inhalation par vapeur, PROPOFOL for Adult patients with severe cardiogenic shock on venoarterial ECMO support for less than 24 hours. is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients with severe cardiogenic shock on venoarterial ECMO support for less than 24 hours.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active